Close

Valeant Pharma (VRX) Names New Chief Quality Officer

October 6, 2016 4:20 PM EDT Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that Louis W. Yu, Ph.D. has been appointed to the newly created position ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login